Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01787370

Ligand	Ligand name	Chain	PDB	Tanimoto
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.73
S2A		A	2OEY	0.74
AKT	10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT)	A	1Q0R	0.71
NGU	U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN	A,B	1D22	0.7
EH5	N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]-[2-(HEXAHYDRO-BENZO[1,3]DIOXOL-5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)-4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE	A	1LF3	0.76
9AR	9-HYDROXY ARISTOLOCHIC ACID	A,B	1FV0	0.71
HWG	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	A,D	1R20	0.71
TMS	N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]-BENZAMIDE	A,B	1X6W	0.71
XN3	N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE	A,B	1K6P	0.72
MNG	MENOGARIL	A,B	202D	0.73
XN2	N-[2-HYDROXY-1-INDANYL]-5-[(2-TERTIARYBUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4-HYDROXY-2-(1-PHENYLETHYL)-PENTANAMIDE	A,B	1K6V	0.72
BNR	BIS-DAUNORUBICIN	B	1AMD	0.71
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.75
NGM	NOGALAMYCIN	A,B,C,D	258D	0.7
NGM	NOGALAMYCIN	A	282D	0.7
NGM	NOGALAMYCIN	A,B	224D	0.7
NGM	NOGALAMYCIN	A,B	245D	0.7
NGM	NOGALAMYCIN	A,B	1QCH	0.7
NGM	NOGALAMYCIN	A	1D17	0.7
NGM	NOGALAMYCIN	A,B	1D21	0.7
NGM	NOGALAMYCIN	A,B	182D	0.7
C01	(2S)-(4-ISOPROPYLPHENYL)[(2-METHYL-3-OXO-5,7-DIPROPYL-2,3-DIHYDRO-1,2-BENZISOXAZOL-6-YL)OXY]ACETATE	A	1ZEO	0.72
CMD	3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)-DOXORUBICIN	A	236D	0.7
REN	(S)-reticuline	A	3FWA	0.71
REN	(S)-reticuline	A	3D2D	0.71
CX6	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	A,B,C,D,E,F	2AL4	0.74
BDA	4-METHYLBENZYL-N-BIS[DAUNOMYCIN]	A	1AL9	0.72
BDA	4-METHYLBENZYL-N-BIS[DAUNOMYCIN]	A	1AGL	0.72
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.71
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.71
DM9	N-HYDROXYMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN	A	482D	0.72
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.79
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.72
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	215D	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	235D	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	234D	0.71
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A,B	2DES	0.71